Galectin-1 mediated suppression of Epstein-Barr virus–specific T-cell immunity in classic Hodgkin lymphoma
- 15 August 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 110 (4), 1326-1329
- https://doi.org/10.1182/blood-2007-01-066100
Abstract
In Hodgkin lymphoma (HL), the malignant Hodgkin Reed-Sternberg cells interact with the host microenvironment to create an immunosuppressive network that protects the lymphoma from immune attack. These mechanisms are not fully understood. We examined the role of the immunomodulatory protein galectin-1 (Gal-1) on Epstein-Barr virus-specific CD8+ T cell responses in HL. Initial studies indicated Gal-1 expression in all in vitro established Hodgkin Reed-Sternberg cell lines. In situ analysis revealed Gal-1 expression in 26 of 42 classic HL, whereas Gal-1 was uniformly negative in nodular lymphocyte predominant HL. Gal-1hi expression was associated with male gender, older patients, reduced CD8+ T cell infiltration at the tumor site, and most importantly, an impaired latent membrane protein 1 and 2-specific CD8+ T-cell responses. In vitro exposure to recombinant Gal-1 inhibited proliferation and interferon-γ expression by Epstein-Barr virus-specific T cells. These observations provide an important link between the Gal-1-mediated immunomodulatory networks and loss of antigen-specific T-cell function in classic HL.Keywords
This publication has 24 references indexed in Scilit:
- Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cellsBlood, 2006
- Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patientsBlood, 2006
- Technology Insight: applications of emerging immunotherapeutic strategies for Epstein–Barr virus-associated malignanciesNature Clinical Practice Oncology, 2005
- Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell deathCell Death & Differentiation, 2004
- Epstein–Barr virus‐associated Hodgkin's lymphomaBritish Journal of Haematology, 2004
- Hodgkin’s Lymphoma: Evolving Concepts with Implications for PracticeHematology-American Society Hematology Education Program, 2004
- Ex Vivo Analysis of T-Cell Responses to Epstein-Barr Virus-Encoded Oncogene Latent Membrane Protein 1 Reveals Highly Conserved Epitope Sequences in Virus Isolates from Diverse Geographic RegionsJournal of Virology, 2003
- The role of cytokines in classical Hodgkin lymphomaBlood, 2002
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTIONAnnual Review of Immunology, 1997